Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Atacand HCT (candesartan cilexetil - hydrochlorothiazide) Tablets, 16-12.5 and 32-12.5 mg, AstraZeneca LP NDA 21-093 9/5/00 9/11/00 9/11/00 7/30/01 Atacand (candesartan cilexetil), Tablets, 4, 8, 16, and 32 mg, AstraZeneca LP NDA 20-838/S019 4/23/03 Atacand (candesartan cilexetil), Tablets, 4, 8, 16, and 32 mg, AstraZeneca LP NDA 20-838/S017 1/22/03 1/27/03 Atacand (candesartan cilexetil), Tablets, 4, 8, 16, and 32 mg AstraZeneca LP NDA 20-838/S015 9/13/02 9/20/02 9/17/02 2/4/03 Atacand (candesartan cilexetil), Tablets, 4, 8, 16, and 32 mg AstraZeneca LP NDA 20-838/S008 6/14/00 6/6/01 Atacand (candesartan cilexetil) Tablets, 4, 8, 16, and 32 mg Astra Merck NDA 20-838 6/4/98 6/8/98 6/8/98 4/11/02 Atacand Indication: for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. | Atacand (candesartan cilexetil) Tablets, AstraZeneca, Labeling Revision | Atacand (candesartan cilexetil) Tablets, AstraZeneca, Labeling Revision | Atacand (candesartan cilexetil) Tablets, AstraZeneca, New or Modified Indication | Atacand (candesartan cilexetil) Tablets, AstraZeneca, New or Modified Indication | Atacand HCT (candesartan cilexetil and hydrochlorothiazide) Tablets, AstraZeneca, Labeling Revision | Atacand HCT (candesartan cilexetil) Tablets, AstraZeneca, Labeling Revision | ATACAND HCT (candesartan cilexetil and hydrochlorothiazide) Tablets, AstraZeneca LP, Formulation Revision | Atacand (candesartan cilexetil) Tablets, AstraZeneca, Efficacy Supplement with Clinical Data to Support ^ FDA's latest approval appears at the bottom of this list. ^                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2009 Betterchem.com